News
FDA approves leucovorin – but not for autism
The FDA stops short of approving leucovorin for autism, but will its clearance for ultra-rare condition CFD-FOLR1 lead to more off-label prescribing?
Sales & Marketing
Sponsored
12 Questions with Steve Sanghera
Steve Sanghera is the CEO and co-founder of Inventus.
News
Novo partners with Hims & Hers again, ending GLP-1 spat
Novo Nordisk and Hims & Hers have set their differences aside, agreeing to work together once again on the sale of GLP-1 agonists.
Sales & Marketing
When women thrive, we all rise
We need to see advancing women as an intentional multiplication that benefits teams, organisations, and communities.
News
Incyte breaks new ground in anal cancer with EU approval
Incyte claims EU approval for Zynyz as the first systemic therapy for anal cancer, as J&J gets the nod for wider use of Akeega in prostate cancer.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
